First mRNA Flu Vaccine Receives FDA Approval

Why it matters locally: The approval of an mRNA flu vaccine by the FDA could influence public health strategies and vaccine distribution efforts across North Dakota, potentially offering new options for flu prevention to residents.

---

The Food and Drug Administration (FDA) approved an mRNA-based flu vaccine for use in the upcoming flu season. Moderna, the vaccine's developer, created this new immunization technology. This approval represents the first time an mRNA flu vaccine has received authorization from the FDA. The vaccine will become available to the public in time for the next seasonal influenza period.